|
MRPS10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.29993843151533E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.60520485792404E-11 |
| Normal-vs-Stage2 |
3.642400E-02 |
| Normal-vs-Stage3 |
5.52220491556454E-11 |
| Normal-vs-Stage4 |
9.73665592596262E-14 |
| Stage1-vs-Stage2 |
6.500600E-03 |
| Stage1-vs-Stage3 |
4.748200E-01 |
| Stage1-vs-Stage4 |
1.482250E-03 |
| Stage2-vs-Stage3 |
3.135500E-03 |
| Stage2-vs-Stage4 |
3.67079999999964E-05 |
| Stage3-vs-Stage4 |
3.257500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53765888910584E-13 |
| Normal-vs-AfricanAmerican |
4.27709999994974E-06 |
| Normal-vs-Asian |
3.62630000028119E-07 |
| Caucasian-vs-AfricanAmerican |
7.671800E-01 |
| Caucasian-vs-Asian |
4.733600E-01 |
| AfricanAmerican-vs-Asian |
4.753600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.15849996052253E-09 |
| Normal-vs-Female |
1.07850395281162E-11 |
| Male-vs-Female |
9.805200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.63762403216606E-12 |
| Normal-vs-Age(41-60Yrs) |
8.02690025558661E-10 |
| Normal-vs-Age(61-80Yrs) |
2.75400000027126E-07 |
| Normal-vs-Age(81-100Yrs) |
9.125900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.110800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.406840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.378770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.787000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.439600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.943000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.741370E-01 |
| Classical-VS-Follicular |
1.6570899999957E-05 |
| Classical-VS-Other |
5.226400E-01 |
| Classical-VS-Normal |
1.6805445923751E-12 |
| Tall-VS-Follicular |
1.68114999999913E-05 |
| Tall-VS-Other |
9.382200E-01 |
| Tall-VS-Normal |
2.29669949725064E-10 |
| Follicular-VS-Other |
6.043600E-02 |
| Follicular-VS-Normal |
9.855800E-03 |
| Other-VS-Normal |
1.502290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.02200000024122E-07 |
| Normal-vs-N1 |
1.17428289314603E-12 |
| N0-vs-N1 |
2.444500E-04 |
|
|
